Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

被引：0
|
作者：
A J Gross
M Busse
J Leonard
H Schumacher
机构：
[1] Marien Krankenhaus,
[2] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2005年 / 8卷
关键词：
benign prostatic hyperplasia; lower urinary tract symptoms; phytotherapy; tamsulosin; postmarketing surveillance study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this observational prospective study was to evaluate the switch from phytotherapy to tamsulosin 0.4 mg once daily (o.d.) on efficacy, sexual function and tolerability in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) who have a poor response to at least 4 weeks of phytotherapy. The switch to tamsulosin 0.4 mg o.d. improves LUTS and related quality of life. Sexual function is also slightly improved. Tamsulosin is as well tolerated as phytotherapy and abnormal ejaculation appears to be no problem. Tamsulosin is perceived by both patients and urologists to be superior to preceding phytotherapy.
引用
收藏
页码：210 / 214
页数：4
相关论文
共 50 条
  • [21] A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
    Rigatti, P
    Brausi, M
    Scarpa, RM
    Porru, D
    Schumacher, H
    Rizzi, CA
    PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (04) : 315 - 323
  • [22] Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Dedhia, Raj C.
    McVary, Kevin T.
    JOURNAL OF UROLOGY, 2008, 179 (06): : 2119 - 2125
  • [23] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Richard Berges
    Klaus Höfner
    Michael Gedamke
    Matthias Oelke
    World Journal of Urology, 2014, 32 : 1163 - 1170
  • [24] α1-adenoceptor antagonists for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: State of the art
    Djavan, B
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 23 - 30
  • [25] Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
    McNaughton-Collins, M
    Barry, MJ
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (12): : 1331 - 1339
  • [26] Integrating patient risk profiles in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in clinical practice
    Speakman, MJ
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 18 - 22
  • [27] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Berges, Richard
    Hoefner, Klaus
    Gedamke, Michael
    Oelke, Matthias
    WORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1163 - 1170
  • [28] Achieving the total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management
    O'Leary, M
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 25 - 33
  • [29] Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
    Cavanaugh, Dana
    Urbanucci, Alfonso
    Mohamed, Nihal E.
    Tewari, Ashutosh K.
    Figueiro, Mariana
    Kyprianou, Natasha
    PROSTATE, 2024, 84 (05): : 417 - 425
  • [30] Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study
    Zhang, Weiyu
    Zhang, Xiaopeng
    Li, Haibin
    Wu, Feng
    Wang, Huanrui
    Zhao, Meishan
    Hu, Hao
    Xu, Kexin
    BMJ OPEN, 2019, 9 (06):
12345